Roxanne E Zeck
Pharmacy in White House Station, NJ
License number
New Jersey 28RW00126900
Issued Date
Jun 8, 2008
Expiration Date
Aug 31, 2012
Category
Pharmacy
Type
Pharmacy Technician
Address
Address
White House Station, NJ
Professional information
Dihydroisoindolones As Allosteric Modulators Of Glucokinase
US Patent:
2009020, Aug 13, 2009
Filed:
Apr 15, 2009
Appl. No.:
12/423948
Inventors:
Haiyan Bian - Princeton NJ, US
Joseph Dudash - Hillsborough NJ, US
Mona Patel - Belle Mead NJ, US
Philip Rybczynski - Somerville NJ, US
Yongzheng Zhang - Hillsborough NJ, US
Mary Pat Beavers - New Hope NJ, US
Maud Urbanski - Flemington NJ, US
Min (Amy) Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
Joseph Dudash - Hillsborough NJ, US
Mona Patel - Belle Mead NJ, US
Philip Rybczynski - Somerville NJ, US
Yongzheng Zhang - Hillsborough NJ, US
Mary Pat Beavers - New Hope NJ, US
Maud Urbanski - Flemington NJ, US
Min (Amy) Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
International Classification:
A61K 39/395, A61K 31/506, A61K 31/497, A61K 31/4439, A61K 31/427
US Classification:
4241301, 51425505, 514256, 514275, 514337, 514365
Abstract:
The present invention relates to compounds of Formula (1),methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.
Substituted Cycloalkylpyrrolones As Allosteric Modulators Of Glucokinase
US Patent:
2007011, May 24, 2007
Filed:
Oct 30, 2006
Appl. No.:
11/554543
Inventors:
Maud Urbanski - Flemington NJ, US
Amy Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
Amy Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
International Classification:
A61K 31/501, A61K 31/497, A61K 31/4709, A61K 31/427, C07D 417/02, C07D 403/02
US Classification:
514252060, 514255050, 514307000, 514314000, 514337000, 514365000, 544238000, 544405000, 546148000, 548181000, 546276700, 546167000
Abstract:
The present invention relates to compounds of Formula (I),
methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.
Substituted Pyrrolones As Allosteric Modulators Of Glucokinase
US Patent:
2007009, May 3, 2007
Filed:
Oct 30, 2006
Appl. No.:
11/554532
Inventors:
Maud Urbanski - Flemington NJ, US
Amy Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
Amy Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
International Classification:
A61K 31/506, A61K 31/497, A61K 31/4439, A61K 31/428, C07D 417/02, C07D 403/02
US Classification:
514255050, 514275000, 514337000, 514365000, 544405000, 544331000, 546277100, 548181000
Abstract:
The present invention relates to compounds of Formula (I),
methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.
Substituted Dihydroisoindolones As Allosteric Modulators Of Glucokinase
US Patent:
2007009, May 3, 2007
Filed:
Oct 30, 2006
Appl. No.:
11/554500
Inventors:
Joseph Dudash - Hillsborough NJ, US
Philip Rybczynski - Somerville NJ, US
Maud Urbanski - Flemington NJ, US
Amy Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
Xiaoyan Zhang - Belle Mead NJ, US
Yongzheng Zhang - Hillsborough NJ, US
Philip Rybczynski - Somerville NJ, US
Maud Urbanski - Flemington NJ, US
Amy Xiang - Bridgewater NJ, US
Roxanne Zeck - Whitehouse Station NJ, US
Xiaoyan Zhang - Belle Mead NJ, US
Yongzheng Zhang - Hillsborough NJ, US
International Classification:
A61K 31/501, A61K 31/497, A61K 31/4709, A61K 31/4439, C07D 403/02
US Classification:
514253060, 514255050, 514314000, 514310000, 514337000, 544238000, 544405000, 546176000, 546148000, 546277100
Abstract:
The present invention relates to compounds of Formula (I),
methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.